用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网最新消息社区报道
关键字  范围   
 
The FDA has recently approved the following devices to be marketed.
2024/10/13 20:33:36 | 浏览:1019 | 评论:0

The FDA has recently approved the following devices to be marketed.

Occlutech ASD Occluder and Occlutech Pistol Pusher – P200032

The Occlutech ASD Occluder is a permanent implant intended to treat an atrial septal defect (ASD). The device has two umbrella-shaped flexible discs with a connection in the middle. When the device is carefully positioned in the ASD, the two discs cover both sides of the atrial septum, closing the hole. After a few months, the device will be covered by a thin layer of tissue.

The FDA has recently approved the following devices to be marketed.

TZ Medical Adult and Pediatric Multi-Function Defibrillation Electrodes and Adaptors – P200005

TZ Medical Multi-Function Defibrillation Electrodes and Adaptors monitor the heart’s rhythm and deliver a pacing or electrical shock from a defibrillator(a device that applies an electric charge to the heart to restore a normal heartbeat)to a person with an arrhythmia.

The FDA has recently approved the following devices to be marketed.


Edwards EVOQUE Tricuspid Valve Replacement System – P230013

The Edwards EVOQUE Tricuspid Valve Replacement System mainly includes an artificial tricuspid valve(called the EVOQUE valve)and a delivery catheter. The EVOQUE valve is made of cow tissue attached to a self-expanding metal(nickel-titanium)frame for support. It can be used to replace the tricuspid valve of the heart without open-heart surgery. The tricuspid valve prevents backflow of blood into the right atrium(upper right chamber of the heart)from the right ventricle(lower right chamber of the heart).

The FDA has recently approved the following devices to be marketed.

Spectra WaveWriter, WaveWriter Alpha, WaveWriter Alpha Prime Spinal Cord Stimulation Systems - P030017/S363

Boston Scientific’s WaveWriter Spinal Cord Stimulation(SCS)Systems are implanted(placed into the body)to help reduce pain that is chronic(long-term)and intractable(difficult to manage)in the legs, arms, or trunk. This supplement expands the Indications for Use to include treatment of low back and leg pain that is difficult to manage without prior back surgery.

The FDA has recently approved the following devices to be marketed.

XACT Carotid Stent System – P040038/S043

The XACT Carotid Stent System is intended to be used to reopen narrowed parts of the carotid arteries in the neck that supply blood to the brain. The system consists of a delivery catheter and a self-expanding metal stent made of nitinol.
This approval expands the indications for the XACT Carotid Stent System to be used during a Transcarotid Artery Revascularization(TCAR)procedure, in which a device is placed in the neck instead of in the thigh in combination with the ENROUTE Transcarotid Neuroprotection System(ENROUTE NPS). The ENROUTE NPS temporarily reverses blood flow at the treatment area to redirect pieces that may become loose during the procedure from potentially traveling to the brain.

The FDA has recently approved the following devices to be marketed.

Xstim Spine Fusion Stimulator – P230025

The Xstim Spine Fusion Stimulator is a bone growth stimulator(BGS)device intended be used on the lower back. The device components include a controller for creating signals, a belt clip, a rechargeable lithium-ion battery pack and charging unit, controller cables, hydrogel electrode pads that stick to the skin, optional electrode covers, including some for use only when showering, and a carry case.

The FDA has recently approved the following devices to be marketed.

INTELLANAV STABLEPOINT™ Ablation Catheter & Force Sensing System on the RHYTHMIA HDX™ Mapping System - P150005/S074

The INTELLANAV STABLEPOINT Ablation Catheter uses radiofrequency(RF)energy applied by the catheter tip to destroy heart tissue cells that are causing heart rhythm problems(arrhythmias).

The FDA has recently approved the following devices to be marketed.

 

Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation Systems – P150031/S064

The Vercise PC, Vercise Gevia, and Vercise Genus Deep Brain Stimulation(DBS)Systems are implantable devices that deliver low-intensity electrical pulses to nerve centers in the brain. This supplement expands the Indications for Use to include an option of two-sided stimulation for people who are diagnosed with essential tremor not adequately controlled by medication and where the tremor creates a significant inability to function.

The FDA has recently approved the following devices to be marketed.

AGENT Paclitaxel-Coated Balloon Catheter – P230035

The AGENT Paclitaxel-Coated Balloon Catheter(Agent DCB)uses a narrow tube with a balloon on the end to reopen arteries that supply blood to the heart and are blocked or narrowed due to coronary artery disease(CAD). The balloon is coated on its outer surface with the drug paclitaxel, which may help prevent the arteries from narrowing again(restenosis).

The FDA has recently approved the following devices to be marketed.

LIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus – P220034

The LIAISON Biotrin Parvovirus B19 IgG Plus is a laboratory test used to detect human parvovirus IgG antibodies against the parvovirus B19 antigen in the blood.

The FDA has recently approved the following devices to be marketed.

 

TriClip G4 System – P230007

The TriClip G4 System is used to treat tricuspid regurgitation(leaky tricuspid valve)often caused by an enlarged heart or damaged tricuspid valve leaflets, without open-heart surgery.

The FDA has recently approved the following devices to be marketed.

ColoSense – P230001

ColoSense is a laboratory test that measures ribonucleic acid(RNA)and hemoglobin(blood)in human stool that is not visible to the eye(fecal occult blood), which may indicate the presence of colorectal cancer or of advanced adenomas(growths on the lining of the colon or rectum). The ColoSense Collection Kit consists of a container for collection of stool and a separate sampler for collection of stool for hemoglobin testing(only one stool is required to obtain both samples). Both samples are required to obtain a ColoSense result. Additionally, bowel prep or following dietary or medication restrictions to complete the test is not necessary.


相关栏目:『社区报道
斯坦福MBA遭网暴!25万刀学费读的竟是“草台班子”...... 2025-09-15 [117]
全天候交易时代来临?贝莱德探索将ETF“代币化” 2025-09-15 [90]
美国学生成绩创历史新低!特朗普政府:教育必须大改革 2025-09-15 [99]
加拿大华人社区怪现象:“会长”满天飞,这是得有多大的官瘾 2025-09-15 [188]
在悲伤之中:悼查理·柯克 2025-09-15 [108]
加州社区学院利用人工智能来打击财政援助欺诈 2025-09-11 [200]
谷歌重大胜利!法院裁决不必出售Chrome浏览器,但将被禁止签独家合约 2025-09-11 [203]
堪称一堂大师课:小肯尼迪的参议院证词轰动了互联网! 2025-09-11 [205]
好家伙!UC伯克利千人人大课惊呆网友,在全美最大的学校读书是怎样一种体验? 2025-09-02 [593]
扎克伯格花14亿办的学校,倒闭了 2025-09-02 [616]
相关栏目更多文章
最新图文:
:摄影师苏唐诗与寂寞百年的故宫对话6年,3万张照片美伦美奂 :大数据分析图解:2019中国企业500强 张梦然:英国惠康桑格研究所:人体内的微生物与出生方式有关 :美众议院将调查华裔部长赵小兰“利用职权为家族谋利“ :UCLA CCS 2019 Fall Quarter Lecture Series Overview 谭晶晶:美国科技界高度关注中国科技创新进展 :推荐:2019年底前中国高校重要学术论坛(10月 - 12 月) :黄奇帆:今后10年,中国经济将发生5个历史性变化
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2025 ScholarsUpdate.com. All Rights Reserved.